
{
  "documentMetadata": {
    "title": "Urethritis, Cervicitis_ Chlamydial",
    "lastUpdated": "2022-10-13",
    "sourceFile": "Urethritis, Cervicitis_ Chlamydial.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Chlamydia, non- or post-gonococcal urethritis or cervicitis.",
        "Concomitant gonorrhea should be assumed. See Gonococcal urethritis/cervicitis.",
        "Evaluate and treat sex partners (and advise to abstain from sex until treatment complete).",
        "Re-test for cure in pregnancy.",
        "For rectal chlamydia, see Comments"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Chlamydia trachomatis (50%)",
        "Mycoplasma hominis",
        "Other known etiologies (10â€“15%):",
        "Trichomonas",
        "H. simplex virus",
        "Mycoplasma genitalium",
        "Ureaplasma urealyticum (controversial)"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "Nucleic acid amplification tests for C. trachomatis and N. gonorrhoeae on urine, urethral, or endocervical sample.",
        "Another alternative is patient collected vaginal swab: New Engl J Med 2017; 367: 765."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Doxycycline",
            "dose": "100 mg",
            "route": "po",
            "frequency": "bid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "7 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "condition": "Pregnancy",
        "components": [
          {
            "drug": "Azithromycin",
            "dose": "1 gm",
            "route": "po"
          }
        ],
        "durationDetail": {
          "fixedDuration": "1 dose"
        }
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "condition": "for urethritis",
        "components": [
          {
            "drug": "Azithromycin",
            "dose": "500 mg",
            "route": "po",
            "notes": "x 1 dose followed by 250 mg po x 4 days"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "condition": "for cervicitis or urethritis",
        "components": [
          {
            "drug": "Azithromycin",
            "dose": "1 gm",
            "route": "po"
          }
        ],
        "durationDetail": {
          "fixedDuration": "1 dose"
        },
        "notes": "Some evidence that single dose regimen more likely to select for resistant M. genitalium"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Mycoplasma genitalium is associated with 30% of non-gonococcal urethritis (NGU), cervicitis, and pelvic inflammatory disease (PID) (Clin Infect Dis 56:934, 2013) and may account for treatment failures. Macrolide resistance found in almost 40% of M. genitalium-positive patients tested in STI clinic patients in Denmark (Clin Infect Dis 59:24 (Jul 1), 2014). Resistance increasing world wide, with increasing resistance to fluoroquinolones. See 2021 CDC STI guidelines for explanation of new 2 stage treatment",
        "Macrolide treatment also associated with increased resistance of other pulmonary and Gl microbes."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Pregnancy",
        "All pregnant women should be screened for chlamydia infection on initial prenatal visit.",
        "Doxycycline and Fluoroquinolones are contraindicated for use during pregnancy.",
        "If patient fails treatment for Chlamydia trachomatis, possibilities are:",
        "Trichomonas vaginalis",
        "Mycoplasma genitalium",
        "Herpes simplex",
        "All patients with chlamydia infection should be tested for HIV.",
        "Rectal chlamydia:",
        "Prevalence of 6% but up to 68% among women with vaginal chlamydia",
        "In cohort study, microbiologic cure with single dose azithromycin 78.5% vs 95.5% with 7 days of doxycycline bid.Sex Transm Dis 2014 41:79",
        "In RCT in MSM with rectal Chlamydia doxycycline 100 bid superior to azithromycin (100% vs. 74% microbiological cure). Clin Infect Dis 2021 doi: 10.1093/cid/ciab153.",
        "Preponderance of evidence indicates Doxycycline is more efficacious for rectal chlamydia and in men with urogenital symptoms. Clin Infect Dis 74:S112 2022",
        "Treat LGV for 3 weeks with doxycycline.",
        "See 2021 CDC STI guidelines MMWR Recomm Rep 70 (RR-4):1 2021",
        "Review of evidence for CDC guidelines: Clin Infect Dis 74:S95 2022 (Gonorrhea) and Clin Infect Dis 74:S112 2022 (Chlamydia)"
      ]
    }
  ]
}
